TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) CEO Waleed H. Hassanein sold 8,625 shares of the firm’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $153.42, for a total transaction of $1,323,247.50. Following the transaction, the chief executive officer now directly owns 61,643 shares in the company, valued at approximately $9,457,269.06. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
TransMedics Group Stock Up 3.2 %
TransMedics Group stock traded up $4.87 during mid-day trading on Tuesday, hitting $156.08. The company’s stock had a trading volume of 821,976 shares, compared to its average volume of 773,351. The company has a market cap of $5.21 billion, a PE ratio of -459.06 and a beta of 1.99. TransMedics Group, Inc. has a 52-week low of $36.42 and a 52-week high of $177.37. The company has a debt-to-equity ratio of 2.67, a current ratio of 9.37 and a quick ratio of 8.48. The firm’s 50 day moving average is $154.40 and its 200 day moving average is $127.98.
TransMedics Group (NASDAQ:TMDX – Get Free Report) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.21 by $0.14. The business had revenue of $114.30 million for the quarter, compared to analysts’ expectations of $98.84 million. TransMedics Group had a net margin of 0.84% and a return on equity of 15.98%. TransMedics Group’s revenue was up 117.7% on a year-over-year basis. During the same period in the previous year, the company posted ($0.03) EPS. On average, analysts anticipate that TransMedics Group, Inc. will post 1.23 earnings per share for the current year.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on TransMedics Group
Hedge Funds Weigh In On TransMedics Group
Hedge funds have recently added to or reduced their stakes in the company. Sanctuary Advisors LLC bought a new stake in TransMedics Group in the second quarter worth approximately $372,000. Teachers Retirement System of The State of Kentucky acquired a new position in TransMedics Group during the second quarter worth $420,000. NewEdge Advisors LLC raised its holdings in TransMedics Group by 26.0% during the second quarter. NewEdge Advisors LLC now owns 10,372 shares of the company’s stock valued at $1,562,000 after buying an additional 2,140 shares in the last quarter. Creative Planning lifted its position in shares of TransMedics Group by 78.3% in the second quarter. Creative Planning now owns 9,173 shares of the company’s stock worth $1,382,000 after buying an additional 4,027 shares during the last quarter. Finally, Algert Global LLC bought a new stake in shares of TransMedics Group during the 2nd quarter worth about $2,685,000. Institutional investors and hedge funds own 99.67% of the company’s stock.
TransMedics Group Company Profile
TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Featured Articles
- Five stocks we like better than TransMedics Group
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- CD Calculator: Certificate of Deposit Calculator
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for TransMedics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransMedics Group and related companies with MarketBeat.com's FREE daily email newsletter.